Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score

AIM: To evaluate active surveillance (AS) selection, safety and durability among men with low-risk prostate cancer assessed using the clinical cell cycle risk (CCR) score, a combined clinical and molecular score. PATIENTS & METHODS: Initial treatment selection (AS vs treatment) and duration of A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaul, Sanjeev, Wojno, Kirk J, Stone, Steven, Evans, Brent, Bernhisel, Ryan, Meek, Stephanie, D’Anna, Richard E, Ferguson, Jeffrey, Glaser, Jeffrey, Morgan, Todd M, Lieb, Jeremy, Yan, Robert, Cohen, Todd, Ehdaie, Behfar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447833/
https://www.ncbi.nlm.nih.gov/pubmed/31483217
http://dx.doi.org/10.2217/pme-2019-0084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447833/
https://www.ncbi.nlm.nih.gov/pubmed/31483217
http://dx.doi.org/10.2217/pme-2019-0084

Ejemplares similares